Resmed Dividend 2024

Resmed Dividend

1.84 USD

Resmed Dividend yield

0.85 %

Ticker

RMD

ISIN

US7611521078

WKN

895878

How much dividend does Resmed 2024 pay?

According to the latest status from May 2024, Resmed paid a total of 1.84 USD per share in dividends within the last 12 months. With the current Resmed price of 216.94 USD, this corresponds to a dividend yield of 0.85 %. A dividend is paid 4 times per year.

0.85 % Dividend Yield=
1.84 USD Dividend
216.94 USD Stock Price

Historical Resmed Dividends

A dividend is paid 4 times per year. Last year, the payout months were March, June, September and December.

PaydateDividend
6/8/20240.48
3/7/20240.48
12/8/20230.48
9/16/20230.48
6/10/20230.44
3/8/20230.44
12/9/20220.44
9/17/20220.44
6/11/20220.42
3/9/20220.42
12/9/20210.42
9/18/20210.42
6/12/20210.39
3/10/20210.39
12/10/20200.39
9/19/20200.39
6/13/20200.39
3/12/20200.39
12/6/20190.39
9/14/20190.39
1
2
3

Resmed Stock Dividend

Details

Dividend

Dividend Overview

The dividend per year chart for Resmed provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Resmed’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Resmed's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Resmed Dividend History

DateResmed Dividend
2029e2.1 undefined
2028e2.1 undefined
2027e2.1 undefined
2026e2.1 undefined
2025e2.11 undefined
2024e2.09 undefined
20231.84 undefined
20221.72 undefined
20211.62 undefined
20201.56 undefined
20191.52 undefined
20181.44 undefined
20171.36 undefined
20161.26 undefined
20151.16 undefined
20141.06 undefined
20130.84 undefined
20120.34 undefined

Is the Resmed Dividend Safe?

Resmed has been increasing the dividend for 11 years.

Over the past 10 years, Resmed has increased it by an annual 8.157 %.

Over a five-year period, the distribution increased by 5.025%.

Analysts expect a Dividend Increase of 6.655% for the current fiscal year.

Dividend Details

Understanding Resmed's Dividend Distributions

Resmed’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Resmed's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Resmed's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Resmed’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Resmed Aktienanalyse

What does Resmed do?

ResMed Inc. is a global leading provider of medical devices for the treatment of sleep disorders and respiratory diseases. The company was founded in Australia by Peter Farrell, a former employee of the University of New South Wales, in 1989. Today, ResMed is headquartered in San Diego, California, and employs over 7,500 people worldwide. Business model: ResMed's business model is based on providing medical products and solutions for the treatment of sleep apnea and other respiratory diseases. The company develops and distributes masks, devices, and accessories that help patients breathe better and achieve restful sleep. ResMed also offers cloud-based software solutions and services to assist doctors and sleep labs in diagnosing and monitoring patients. Products and divisions: ResMed's product range can be divided into four main divisions: Sleep & Respiratory Care, Software as a Service (SaaS), Technologies, and Dental Solutions. Sleep & Respiratory Care: In this division, ResMed offers a wide range of masks, devices, and accessories for the treatment of sleep apnea and other respiratory diseases. The most well-known products include the AirSense and AirMini devices, equipped with Automatic Sleep Detection and AutoSet algorithm to optimize respiratory pressure. ResMed also offers a range of CPAP masks, nasal and full face masks, as well as nasal pillow masks. Software as a Service (SaaS): ResMed's cloud-based software solutions and services are offered under the brand AirView. They include diagnostic tools, patient monitoring systems, and analysis tools. AirView allows doctors to access their patients' medical data captured by ResMed devices and monitor this data in real-time. Technologies: ResMed's Technologies division focuses on the development of advanced sensors for respiratory and sleep monitoring. Products include the S+, a smart sleep tracking system that operates without direct body contact, and the Reveal-LTE, an implant for monitoring heart and respiratory rates in patients with heart failure. Dental Solutions: ResMed has also developed products for dentistry to assist patients with mild to moderate upper airway obstruction. Products include the Narval CC, a custom-made dental device for the treatment of snoring and sleep apnea, and the Tap Pap nasal pillow oral appliance, a non-invasive mouthguard. Conclusion: ResMed is a leading provider of medical devices and solutions for the treatment of sleep apnea and other respiratory diseases. The company offers innovative products and technologies that help patients breathe better and achieve restful sleep. ResMed's cloud-based software solutions enable doctors to monitor their patients' health in real-time and develop effective diagnosis and treatment strategies. With its wide range of products, innovation, and highly qualified team of scientists, engineers, and medical professionals, ResMed will continue to play an important role in the healthcare industry. Resmed is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Resmed stock can be added to a savings plan with the following providers: Trade Republic

Frequently Asked Questions about Resmed Stock

How much dividend does Resmed pay?

Over the past 12 months, Resmed paid a dividend of 1.84 USD . This corresponds to a dividend yield of about 0.85 %. For the coming 12 months, Resmed is expected to pay a dividend of 2.11 USD.

What is the dividend yield of Resmed?

The current dividend yield of Resmed is 0.85 %.

When does Resmed pay dividends?

Resmed pays a quarterly dividend. This is distributed in the months of September, December, March, June.

How secure is the dividend of Resmed?

Resmed paid dividends every year for the past 0 years.

What is the dividend of Resmed?

For the upcoming 12 months, dividends amounting to 2.11 USD are expected. This corresponds to a dividend yield of 0.97 %.

In which sector is Resmed located?

Resmed is assigned to the 'Health' sector.

Wann musste ich die Aktien von Resmed kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Resmed from 6/13/2024 amounting to 0.48 USD, you needed to have the stock in your portfolio before the ex-date on 5/8/2024.

When did Resmed pay the last dividend?

The last dividend was paid out on 6/13/2024.

What was the dividend of Resmed in the year 2023?

In the year 2023, Resmed distributed 1.72 USD as dividends.

In which currency does Resmed pay out the dividend?

The dividends of Resmed are distributed in USD.

Andere Kennzahlen von Resmed

Our stock analysis for Resmed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Resmed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.